Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline (GSK) and Pfizer (PFE)
Pfizer (PFE) Will Make $120 Billion Bid for GlaxoSmithKline (GSK) in Second Quarter, Says Poll
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV)
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial
New FDA Warning Impacts Diabetes Drugs Made by AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) and Eli Lilly (LLY)
Judge Berates Bayer (BAY) for Offering to Reinstate Whistleblowing Sales Rep With a Job 500 Miles Away
Another High Level Exec Flees Sanofi (SAN.PA), As C-Level Shuffle Continues
ASCO’s Most Important Abstracts: BioSpace (DHX)’s Cheat Sheet for You
Analysts Question Intercept Pharma (ICPT) NASH Trial Phase III Length and Size
Amgen (AMGN), Sanofi (SAN.PA) in Race to Get European Green light for Anti-Cholesterol Drugs
Wall Street Cheers As Sarepta (SRPT) Soars 50% Premarket on Muscular Dystrophy Drug Filing
Valeant (VRX) in Talks to Pay $700 to $800 Million for Egyptian Drugmaker Amoun to Expand GI Line
Twitter Attempts to Marry Gilead (GILD), Achillion (ACHN), Finds Reality Instead
REGENXBIO Banks $70.5 Million As Gene Therapy Enjoys Revival
Investors Rejoice as bluebird bio (BLUE) Plots Road to First-Ever U.S. Gene Therapy Approval
Medicago's $245 Million Facility Will Create 200 New Jobs, 40 Million New Vaccine Doses
New York's Kinex Expected to Hire 80 to 240 Immediately, 800 Over Next Two Years
See All News >
//-->